31![6.1 PHARMACOVIGILANCE PART OF THE CMDh MINUTES[removed]December 2012 meeting Chairperson: Peter Bachmann The Chairperson opened the meeting and welcomed all participants to the[removed]December 2012 meeting of the CMDh. 6.1 PHARMACOVIGILANCE PART OF THE CMDh MINUTES[removed]December 2012 meeting Chairperson: Peter Bachmann The Chairperson opened the meeting and welcomed all participants to the[removed]December 2012 meeting of the CMDh.](https://www.pdfsearch.io/img/e44dd6d9a7c6a457210ee7708dd34568.jpg) | Add to Reading ListSource URL: www.hma.euLanguage: English - Date: 2013-02-08 07:13:19
|
---|
32![6.1 PHARMACOVIGILANCE PART OF THE CMDh AGENDA[removed]December 2012 meeting Chairperson: Peter Bachmann 1. 6.1 PHARMACOVIGILANCE PART OF THE CMDh AGENDA[removed]December 2012 meeting Chairperson: Peter Bachmann 1.](https://www.pdfsearch.io/img/20b3cb56a6f779c13da69e8a84a42dee.jpg) | Add to Reading ListSource URL: www.hma.euLanguage: English - Date: 2012-12-10 11:05:04
|
---|
33![Required Drug Classes for 90 Day Maintenance Fill at Retail Drug Class Antihyperlipidemics Drug Sub-Class Required Drug Classes for 90 Day Maintenance Fill at Retail Drug Class Antihyperlipidemics Drug Sub-Class](https://www.pdfsearch.io/img/f5665aa052d35fd78e058d595b4253cc.jpg) | Add to Reading ListSource URL: dvha.vermont.govLanguage: English - Date: 2013-05-21 21:10:49
|
---|
34![Microsoft PowerPoint[removed]Introduction (CI) Microsoft PowerPoint[removed]Introduction (CI)](https://www.pdfsearch.io/img/cdf543317e567364c6b96d7a6627c68d.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2009-01-05 11:05:24
|
---|
35![Orthro Tri-Cyclen presentation June9.ppt Orthro Tri-Cyclen presentation June9.ppt](https://www.pdfsearch.io/img/e48c569851c47269e8e3647e84cea3f6.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2009-01-05 11:05:18
|
---|
36![Model Respiratory Distress Model Respiratory Distress](https://www.pdfsearch.io/img/ae1064d46674b37193ca996ea725e667.jpg) | Add to Reading ListSource URL: www.ncems.orgLanguage: English - Date: 2013-01-10 08:42:41
|
---|
37![Required Drug Classes for 90 Day Maintenance Fill at Retail Drug Class Antihyperlipidemics Drug Sub-Class Required Drug Classes for 90 Day Maintenance Fill at Retail Drug Class Antihyperlipidemics Drug Sub-Class](https://www.pdfsearch.io/img/793027efba1f6be0961c9bdcae3a11ed.jpg) | Add to Reading ListSource URL: dvha.vermont.govLanguage: English - Date: 2013-05-21 21:10:49
|
---|
38![Long-acting Beta-agonists: Asthma Intubations and Deaths Shelley Salpeter, MD, FACP Stanford University School of Medicine
Long-acting Beta-agonists: Long-acting Beta-agonists: Asthma Intubations and Deaths Shelley Salpeter, MD, FACP Stanford University School of Medicine
Long-acting Beta-agonists:](https://www.pdfsearch.io/img/b55e8b2aa0964aff56a76bc4c162974f.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English - Date: 2009-01-05 11:05:27
|
---|
39![FORADIL AEROLIZER (formoterol fumarate inhalation powder) FORADIL AEROLIZER (formoterol fumarate inhalation powder)](https://www.pdfsearch.io/img/eca54bb6fc3cb9b4928e40b6ca34cb8a.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2012-09-28 10:26:06
|
---|
40![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BROVANA® safely and effectively. See full prescribing information for BROVANA. BROVANA® (arformoterol tartrate) In HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BROVANA® safely and effectively. See full prescribing information for BROVANA. BROVANA® (arformoterol tartrate) In](https://www.pdfsearch.io/img/754b0405180e0dec66ef10edec72b191.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2014-03-04 13:22:49
|
---|